Back to Search
Start Over
Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial
- Source :
- Radiotherapy and Oncology, Vol. 139 (2019) pp. 83-86
- Publication Year :
- 2019
-
Abstract
- The ONE SHOT trial is the first phase I/II prospective, multicenter, single-arm study assessing the efficacy and safety of a single-dose SBRT for men with localized prostate cancer. Aim of this paper is to present the phase I results of a 19 Gy single fraction urethra-sparing SBRT with real-time electromagnetic tracking.
- Subjects :
- Male
medicine.medical_specialty
2720 Hematology
Phase (waves)
610 Medicine & health
Radiosurgery
ddc:616.0757
030218 nuclear medicine & medical imaging
03 medical and health sciences
Prostate cancer
0302 clinical medicine
Urethra
medicine
2741 Radiology, Nuclear Medicine and Imaging
Humans
Radiology, Nuclear Medicine and imaging
Prospective Studies
Electromagnetic tracking
Aged
Aged, 80 and over
One shot
SBRT
Toxicity
business.industry
Prostatic Neoplasms
Hematology
Monotherapy
medicine.disease
10044 Clinic for Radiation Oncology
Single fraction
medicine.anatomical_structure
Oncology
Phase I/II trial
Radiology Nuclear Medicine and imaging
030220 oncology & carcinogenesis
2730 Oncology
Radiology
business
Radiotherapy, Image-Guided
Subjects
Details
- ISSN :
- 18790887 and 01678140
- Volume :
- 139
- Database :
- OpenAIRE
- Journal :
- Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
- Accession number :
- edsair.doi.dedup.....66ccbacf5a35b696edcfc1284c8b6cc0